mug100 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Context

The "mug100 Antibody" refers to 100 microgram doses of anti-D immunoglobulin administered to prevent Rh(D) alloimmunization in Rh-negative mothers delivering Rh-positive infants. This dosage was evaluated in landmark clinical trials comparing efficacy across multiple concentrations .

Clinical Trial Data

A pivotal study compared four anti-D doses in 2,000 D-negative primiparae:

Dose (µg)Sensitization Rate at 6 MonthsFailure Rate in Subsequent Pregnancy
2000.22%1.5%
1000.23%1.1%
500.44%1.5%
201.35%2.9%

Key findings:

  • 100 µg showed comparable efficacy to 200 µg in preventing Rh sensitization

  • Statistical significance (P=0.02) confirmed dose-response relationship

  • 20 µg dose deemed suboptimal for routine use

Mechanism of Action

The 100 µg anti-D formulation functions through:

  1. Erythrocyte clearance: Opsonizes fetal Rh+ red blood cells for phagocytosis

  2. Immune modulation:

    • Blocks maternal B-cell recognition of Rh antigen

    • Suppresses antigen presentation through Fc-mediated mechanisms

  3. Complement inhibition: Prevents membrane attack complex formation on fetal cells

Comparative Pharmacokinetics

While specific data for the 100 µg formulation is limited, anti-D antibodies generally exhibit:

ParameterValue RangeSource
Half-life21-28 days
Peak concentration15-30 µg/mL
Bioavailability>90% (IM administration)

Modern Therapeutic Context

Recent advances in monoclonal antibody engineering demonstrate improved features over traditional polyclonal anti-D:

FeatureTraditional Anti-D (100 µg)Engineered mAbs (e.g., L9LS)
Production methodPlasma-derivedRecombinant CHO cells
SpecificityPolyclonalMonoclonal
Half-life3 weeks6-12 months
Administration routeIntramuscularSubcutaneous
Viral safety risksLow but presentNone

Sources:

Current Applications and Limitations

While largely superseded by 150-300 µg doses in modern practice, the 100 µg regimen remains significant for:

  • Cost-sensitive healthcare systems

  • Weight-based dosing in low-BMI populations

  • Historical comparison studies in transfusion medicine

Limitations include reduced efficacy against large fetomaternal hemorrhages (>30 mL) .

Research Directions

Ongoing developments building on 100 µg anti-D principles:

  1. Bispecific antibodies targeting RhD + complement regulators

  2. Subcutaneous formulations with extended half-lives

  3. Gene-edited B-cells producing endogenous anti-D

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
mug100 antibody; SPBC16E9.07 antibody; Meiotically up-regulated gene 100 protein antibody; mitochondrial antibody
Target Names
mug100
Uniprot No.

Target Background

Function
Plays a role in meiosis.
Database Links
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is mug100 antibody and what organism does it target?

The mug100 antibody is a rabbit polyclonal antibody that targets the mug100 protein from Schizosaccharomyces pombe (fission yeast). It is produced through antigen affinity purification and is available in unconjugated form. The antibody specifically recognizes the recombinant S. pombe (strain 972/ATCC 24843) mug100 protein, which has a UniProt number of O14322 and an Entrez Gene ID of 2540147 .

What applications is mug100 antibody validated for?

According to product specifications, mug100 antibody is validated for ELISA (Enzyme-Linked Immunosorbent Assay) and WB (Western Blot) applications. These techniques allow researchers to detect the presence and relative abundance of the target protein in experimental samples. The antibody comes with 200μg of antigens (which can serve as a positive control) and 1ml of pre-immune serum (as a negative control) to facilitate experimental validation .

How should mug100 antibody be stored to maintain its activity?

For optimal preservation of activity, mug100 antibody should be stored at either -20°C or -80°C. Proper storage is critical for maintaining antibody functionality, as repeated freeze-thaw cycles can lead to protein denaturation and reduced binding efficacy. When working with the antibody, it's advisable to aliquot it into smaller volumes to minimize freeze-thaw cycles .

What controls should be included when using mug100 antibody in experiments?

When designing experiments with mug100 antibody, researchers should include multiple controls:

  • Positive control: Use the provided antigens (200μg) to confirm antibody binding specificity

  • Negative control: Include the pre-immune serum (1ml) to identify non-specific binding

  • Loading control: For Western blots, include a housekeeping protein control

  • No-primary antibody control: To assess secondary antibody non-specific binding

  • Isotype control: Consider using rabbit IgG isotype control to distinguish specific from non-specific binding

These controls help validate results and troubleshoot potential issues with antibody specificity or experimental conditions.

How should I determine the optimal concentration of mug100 antibody for my experiment?

Determining the optimal working concentration requires titration experiments:

  • For Western blot: Test a range of antibody dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000) using the same sample

  • For ELISA: Create a standard curve with serial dilutions (typically 1:100 to 1:10,000)

  • Analyze signal-to-noise ratio at each concentration

  • Select the dilution that provides optimal specific signal while minimizing background

The optimal concentration will depend on your specific experimental conditions, including sample preparation, detection method, and expression level of the target protein .

How can I optimize Western blot protocols specifically for mug100 antibody?

Optimizing Western blot protocols for mug100 antibody requires attention to several parameters:

  • Sample preparation:

    • For yeast samples, use appropriate lysis buffers containing protease inhibitors

    • Heat samples at 95°C for 5 minutes in reducing sample buffer

    • Load 20-50μg of total protein per lane

  • Blocking optimization:

    • Test different blocking agents (5% BSA vs. 5% non-fat milk)

    • Block membranes for 1 hour at room temperature or overnight at 4°C

  • Antibody incubation:

    • Dilute antibody in fresh blocking buffer

    • Incubate primary antibody overnight at 4°C with gentle rocking

    • Perform at least 3-4 washes with TBST (5 minutes each)

  • Detection system:

    • Use HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000)

    • Consider enhanced chemiluminescence (ECL) for detection

    • For weak signals, explore signal enhancement systems or longer exposure times

This methodological approach takes advantage of the antibody's IgG isotype and affinity purification to maximize specific binding while reducing background .

What strategies can improve specificity when using polyclonal mug100 antibody?

Because mug100 antibody is polyclonal, researchers may encounter specificity challenges. To improve specificity:

  • Pre-absorption technique:

    • Incubate diluted antibody with excess non-specific proteins

    • This removes antibodies that might cross-react with unintended targets

  • Increased washing stringency:

    • Use higher salt concentration in wash buffers (up to 500mM NaCl)

    • Add 0.1-0.2% SDS to wash buffers for more stringent conditions

    • Increase number and duration of washes

  • Epitope blocking:

    • Pre-incubate with specific blocking peptides when available

    • Compare blocked vs. unblocked antibody signals to confirm specificity

  • Sequential probing:

    • For co-staining experiments, use sequential rather than simultaneous antibody incubations

    • Include thorough washing steps between applications

These approaches help mitigate the inherent variability of polyclonal antibodies while maximizing specific target recognition .

What are common sources of false positive or negative results when using mug100 antibody?

Understanding potential sources of error helps with accurate data interpretation:

Source of ErrorFalse Positive CausesFalse Negative CausesMitigation Strategy
Sample preparationProtein degradation, Incomplete denaturationInadequate protein extraction, Epitope maskingUse fresh samples, Optimize lysis buffers, Test different detergents
Blocking conditionsInsufficient blocking, Antibody cross-reactivityOver-blocking, Epitope maskingOptimize blocking agent concentration and time
Antibody concentrationToo concentrated, Non-specific bindingToo dilute, Insufficient bindingPerform antibody titration experiments
Washing proceduresInsufficient washingExcessive washingOptimize wash buffer composition and wash steps
Detection systemDetector saturation, Chemiluminescent substrate depletionInsufficient exposure time, Detector sensitivity limitsAdjust exposure settings, Consider alternative detection methods

Recognizing these patterns helps researchers discriminate between genuine results and technical artifacts .

How can I validate the specificity of mug100 antibody for my particular application?

Comprehensive validation strategies include:

  • Genetic knockdown/knockout experiments:

    • Compare antibody signal in wild-type vs. mug100-depleted samples

    • Signal should be reduced or eliminated in knockout/knockdown samples

  • Mass spectrometry validation:

    • Perform immunoprecipitation with mug100 antibody

    • Analyze precipitated proteins by mass spectrometry

    • Confirm presence of target protein and identify potential cross-reacting proteins

  • Recombinant protein expression:

    • Express tagged versions of mug100 protein

    • Compare detection by both mug100 antibody and tag-specific antibody

    • Signals should co-localize or show similar patterns

  • Peptide competition assay:

    • Pre-incubate antibody with excess immunogen peptide

    • Compare signal with and without competition

    • Specific signal should be reduced after competition

Can mug100 antibody be used for immunoprecipitation or chromatin immunoprecipitation studies?

While the mug100 antibody is primarily validated for ELISA and Western blot applications, researchers interested in immunoprecipitation (IP) or chromatin immunoprecipitation (ChIP) should consider:

  • Pilot experiment design:

    • Test different antibody amounts (2-10μg per reaction)

    • Evaluate different binding conditions (4°C vs. room temperature)

    • Compare protein A vs. protein G beads for rabbit IgG capture

    • Include appropriate negative controls (non-specific rabbit IgG)

  • Protocol optimization:

    • Adjust crosslinking conditions for ChIP (if applicable)

    • Test different lysis buffers with varying detergent concentrations

    • Optimize wash stringency to balance specific binding vs. background

  • Validation approaches:

    • Confirm presence of target protein in eluates by Western blot

    • For ChIP, validate enrichment using qPCR of known binding sites

    • Consider peptide competition controls to confirm specificity

While these applications would require additional validation beyond the manufacturer's specifications, the antibody's polyclonal nature and affinity purification suggest potential utility in these techniques .

What are the considerations for using mug100 antibody in studies of protein-protein interactions?

When investigating protein-protein interactions involving mug100:

  • Co-immunoprecipitation strategies:

    • Use mug100 antibody to pull down protein complexes

    • Analyze co-precipitated proteins by Western blot or mass spectrometry

    • Consider crosslinking approaches to stabilize transient interactions

    • Include appropriate controls to distinguish specific from non-specific interactions

  • Proximity ligation assay (PLA) applications:

    • Combine mug100 antibody with antibodies against potential interacting partners

    • Optimize antibody dilutions to minimize background

    • Include negative controls (omitting one primary antibody)

    • Quantify interaction signals across multiple experimental conditions

  • Methodological considerations:

    • Use mild lysis conditions to preserve protein complexes

    • Consider native vs. denaturing conditions based on research questions

    • Validate interactions using complementary techniques (e.g., yeast two-hybrid, FRET)

These approaches allow researchers to move beyond simple protein detection to explore functional protein networks involving mug100 .

How does the specificity of polyclonal mug100 antibody compare with monoclonal antibodies in research applications?

Understanding the comparative advantages and limitations of polyclonal versus monoclonal antibodies helps researchers select appropriate tools:

CharacteristicPolyclonal mug100 AntibodyTypical Monoclonal AntibodiesResearch Implications
Epitope recognitionMultiple epitopes on target antigenSingle epitopePolyclonals offer robust detection but potential cross-reactivity; monoclonals provide high specificity but may be affected by epitope masking
Batch-to-batch variabilityModerate to highLowMonoclonals provide more consistent results across experiments
SensitivityGenerally higher due to multiple binding sitesCan be lower due to single epitopePolyclonals may detect lower abundance proteins
Tolerance to protein modificationsHigher (recognizes multiple epitopes)Lower (single epitope may be modified)Polyclonals better for detecting denatured proteins
Species cross-reactivityOften higherUsually more species-specificConsider experimental organism when selecting antibody

For mug100 antibody specifically, its polyclonal nature provides advantages for detecting the target protein across various experimental conditions, though researchers should implement appropriate controls to address potential cross-reactivity .

What approaches can be used to characterize antibody binding affinity and specificity for mug100?

Advanced researchers may need to characterize the binding properties of mug100 antibody:

  • Surface Plasmon Resonance (SPR) analysis:

    • Immobilize purified mug100 protein on sensor chip

    • Flow antibody at different concentrations

    • Determine association (kon) and dissociation (koff) rates

    • Calculate equilibrium dissociation constant (KD)

  • Enzyme-Linked Immunosorbent Assay (ELISA) titration:

    • Coat plates with varying concentrations of mug100 protein

    • Test different antibody concentrations

    • Generate binding curves and calculate half-maximal binding

  • Epitope mapping approaches:

    • Test antibody binding to peptide arrays covering mug100 sequence

    • Identify specific regions recognized by antibody populations

    • Compare binding to wild-type vs. mutant versions of the protein

  • Cross-reactivity assessment:

    • Test binding against related proteins from different species

    • Evaluate potential off-target binding using protein arrays

    • Perform immunoprecipitation followed by mass spectrometry

These methodologies provide quantitative and qualitative insights into antibody performance characteristics, enabling more precise experimental design and interpretation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.